PI 828 free base · Synonyms: PI-828 · PI828
PI-828 is a dual PI3K and casein kinase 2 inhibitor.
For research use only. Not for human or veterinary use.
Research area
Cancer
Purity >98%
Stock Inquire
PI 828 structure
CAS No.: 942289-87-4
Pack sizes & pricing
| Size | Price | SKU | Stock | |
|---|---|---|---|---|
| 250 mg | USD 620.00 | BP-01363-250mg | In stock | Get quote |
| 500 mg | USD 980.00 | BP-01363-500mg | In stock | Get quote |
| 1 g | USD 1,600.00 | BP-01363-1g | In stock | Get quote |
| 2 g | USD 2,550.00 | BP-01363-2g | In stock | Get quote |
| 3 g | USD 3,080.00 | BP-01363-3g | In stock | Get quote |
| 5 g | USD 3,980.00 | BP-01363-5g | In stock | Get quote |
Description
PI-828 is a dual PI3K and casein kinase 2 (CK2) inhibitor with IC50s of 173 nM, 149 nM, and 1127 nM for p110α, CK2, and CK2α2 in lipid kinase assay, respectively.
Biological activity
In Vitro PI-828 (0.01-100 μM) exhibits cytotoxic effect on the 4T1 breast cancer cells and 4306 ovarian cancer cells. PI-828 (0.78-3.12 µM; 48 hours) decreases caspase 3 activation; higher concentrations of PI-828 (6.25-12.5 μM) alone causes apoptosis.
Identifiers
- SMILES
-
O=C1C=C(N2CCOCC2)OC3=C(C4=CC=C(N)C=C4)C=CC=C13 - InChIKey
-
WUKMIBOGGXMBAC-UHFFFAOYSA-N
Specifications
- MW (average)
- 322.3578
- Formula
- C19H18N2O3
- CAS No.
- 942289-87-4
- Physical state
- Solid
- Color
- white to yellow
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder 4℃ 2 years; In solvent -20℃ 1 month;
Solubility
soluble in DMSO
Documents
References
[1]. Gharbi SI, et al. Exploring the specificity of the PI3K family inhibitor LY294002. Biochem J. 2007 May 15;404(1):15-21.
[2]. Kulkarni AA, et al. Supramolecular nanoparticles that target phosphoinositide-3-kinase overcome insulin resistance and exert pronounced antitumor efficacy. Cancer Res. 2013 Dec 1;73(23):6987-97.
[3]. Zellefrow CD, et al. Identification of druggable targets for radiation mitigation using a small interfering RNA screening assay. Radiat Res. 2012 Sep;178(3):150-9.
Same target
Search PI3K- BP-00104 BMS-986397 free base · >98%
- BP-00923 MTX-531 free base · >98%
- BP-01673 Casein Kinase II Inhibitor IV free base · >98%
- BP-01880 Vps34-IN-1 free base · >98%
- BP-01938 Clifutinib free base · >98%
- BP-02015 IHMT-PI3Kδ-372 free base · >98%
- BP-02016 IHMT-PI3Kδ-372 free base · >98%
- BP-02119 PI-103 free base · >98%
Same research area
Search Cancer- BP-00006 SLF Exclusive free base · >98%
- BP-00008 NSC-339004 free base · >98%
- BP-00019 SLF-amido-C2-COOH free base · >98%
- BP-00020 PT262 free base · >98%
- BP-00022 Inolitazone free base · >98%
- BP-00024 KX2-361 free base · >98%
- BP-00030 EML4-ALK kinase inhibitor 1 free base · >98%
- BP-00037 SB 328437 free base · >98%